AnaptysBio, Inc.

2026 Annual Meeting

MEETING MATERIALS

Annual Report

ANNUAL REPORT

View an enhanced version of our Annual Report.

View Document
Proxy Statement

PROXY STATEMENT

View an enhanced version of our Proxy Statement.

View Document

* Request paper copies of the above proxy materials online now, by email or by phone by dialing 866-648-8133.

VOTING

Please vote your proxy online now or by phone by dialing
866-813-1246.

Vote Now

ANNUAL MEETING

Date & Time:

August 11, 2026
9:00 AM PT

Location

10770 Wateridge Circle, Suite 210
San Diego, California 92121 

ABOUT US


Strategic stewardship of financial collaborations to
deliver shareholder value

AnaptysBio exclusively manages the financial collaborations from Jemperli with GSK and imsidolimab with Vanda, with a focus on protecting and returning their value to stockholders

  • Virtual operating model
  • Less than ~10 FTEs operating as contractors to support the essential functions of a public company
  • Anticipate annualized operating expenses of less than $10 million and a greater than 95% EBIT margin
Learn More